simvastatin has been researched along with Infections, Helicobacter in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CJ; Chen, YA; Feng, CL; Hsu, YM; Kao, CH; Kao, MC; Lai, CH; Liao, WC; Lin, CJ; Lin, CL; Lin, HJ | 1 |
| Abid, A; Abu-Elheja, O; Diab, H; Mahamid, M; Mograbi, J; Nseir, W; Samara, M | 1 |
| Abu-Elheja, O; Mograbi, J; Nseir, W | 1 |
| Howden, CW | 1 |
| Gisbert, JP; McNicholl, AG | 1 |
| Nseir, W | 1 |
| den Hollander, WJ; Kuipers, EJ | 1 |
1 trial(s) available for simvastatin and Infections, Helicobacter
| Article | Year |
|---|---|
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Simvastatin; Treatment Outcome | 2012 |
6 other study(ies) available for simvastatin and Infections, Helicobacter
| Article | Year |
|---|---|
Statins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control Studies.
Topics: Adult; Aged; Antigens, Bacterial; Bacterial Proteins; Case-Control Studies; Cell Line; Cell Line, Tumor; Cholesterol; Epithelial Cells; Female; Helicobacter Infections; Helicobacter pylori; Host-Pathogen Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Incidence; Lovastatin; Male; Middle Aged; Phosphorylation; Population Surveillance; Protein Transport; Simvastatin; Stomach Neoplasms; Taiwan | 2016 |
Commentary: something new to consider in the treatment of Helicobacter pylori infection? Authors' reply.
Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Proton Pump Inhibitors; Simvastatin | 2012 |
Commentary: something new to consider in the treatment of Helicobacter pylori infection?
Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Proton Pump Inhibitors; Simvastatin | 2012 |
Commentary: comparators in H. pylori eradication--stating the ethics of statins.
Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Proton Pump Inhibitors; Simvastatin | 2012 |
Commentary: comparators in H. pylori eradication -- stating the ethics of statins; author's reply.
Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Proton Pump Inhibitors; Simvastatin | 2012 |
Commentary: simvastatin as the key to improving H. pylori eradication rates?
Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Proton Pump Inhibitors; Simvastatin | 2012 |